Gralit India Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.15 Cr
- Revenue Growth 150.88%
- Profit Growth 297.70%
- Ebitda 247.90%
- Net Worth 80.96%
- Total Assets 87.42%
About Gralit India Biotech
Gralit India Biotech Private Limited (GIBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 February 2013 and has a history of 11 years and 11 months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.15 Cr.
Atul Kumar and Gaurav Kumar serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U26960UP2013PTC054957
-
Company No.
054957
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Feb 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Gralit India Biotech Private Limited offer?
Gralit India Biotech Private Limited offers a wide range of products and services, including Essential & Aromatic Oils, Natural Flower Oil, Herb Oil, Mosquito & Insect Repellent, Mosquito Repellent, Home Appliances & Kitchen Appliances, Air Purifier, Artificial & Decorative Candles, Candle, Seeds Oil and Fruit Oils.
Who are the key members and board of directors at Gralit India Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Kumar
|
Director | 12-Feb-2013 | Current |
|
Gaurav Kumar
|
Director | 12-Feb-2013 | Current |
Financial Performance of Gralit India Biotech.
Gralit India Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 150.88% increase. The company also saw a substantial improvement in profitability, with a 297.7% increase in profit. The company's net worth Soared by an impressive increase of 80.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gralit India Biotech?
In 2023, Gralit India Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aerocide Herbal LlpAtul Kumar and Gaurav Kumar are mutual person
-
Gralit Healthcare Private Limited
Atul Kumar and Gaurav Kumar are mutual person
-
Rakshanaya Global Foundation
Atul Kumar and Gaurav Kumar are mutual person
Charges (Loans)
₹11.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2024 | Others | ₹1.00 Cr | Open |
| 30 Jan 2018 | Others | ₹1.50 M | Open |
How Many Employees Work at Gralit India Biotech?
Unlock and access historical data on people associated with Gralit India Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gralit India Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gralit India Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.